Shenzhen Salubris Pharmaceuticals Co Ltd Asset Resilience Ratio

Latest as of September 2025: 4.97%

Shenzhen Salubris Pharmaceuticals Co Ltd asset resilience ratio. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has an Asset Resilience Ratio of 4.97% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shenzhen Salubris Pharmaceuticals Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥545.66 Million

≈ $79.85 Million USD Cash + Short-term Investments

Total Assets

CN¥10.98 Billion

≈ $1.61 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Shenzhen Salubris Pharmaceuticals Co Ltd (2014–2024)

Asset resilience ratio of Shenzhen Salubris Pharmaceuticals Co Ltd from 2014 to 2024. This chart shows how Shenzhen Salubris Pharmaceuticals Co Ltd's Asset Resilience Ratio has changed over time. Read debt load of Shenzhen Salubris Pharmaceuticals Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Salubris Pharmaceuticals Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Shenzhen Salubris Pharmaceuticals Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥545.66 Million	4.97%
Total Liquid Assets	CN¥545.66 Million	4.97%

Asset Resilience Insights

Limited Liquidity: Shenzhen Salubris Pharmaceuticals Co Ltd maintains only 4.97% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Salubris Pharmaceuticals Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shenzhen Salubris Pharmaceuticals Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Shenzhen Salubris Pharmaceuticals Co Ltd Asset Resilience Ratio by Year (2014–2024)

Shenzhen Salubris Pharmaceuticals Co Ltd asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Shenzhen Salubris Pharmaceuticals Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	7.01%	CN¥733.86 Million ≈ $107.39 Million	CN¥10.47 Billion ≈ $1.53 Billion	-2.37pp
2023-12-31	9.38%	CN¥881.57 Million ≈ $129.00 Million	CN¥9.40 Billion ≈ $1.38 Billion	+6.02pp
2022-12-31	3.37%	CN¥328.36 Million ≈ $48.05 Million	CN¥9.76 Billion ≈ $1.43 Billion	+2.72pp
2021-12-31	0.65%	CN¥60.00 Million ≈ $8.78 Million	CN¥9.24 Billion ≈ $1.35 Billion	-2.45pp
2020-12-31	3.10%	CN¥214.59 Million ≈ $31.40 Million	CN¥6.92 Billion ≈ $1.01 Billion	+0.41pp
2019-12-31	2.69%	CN¥208.00 Million ≈ $30.44 Million	CN¥7.73 Billion ≈ $1.13 Billion	-4.90pp
2018-12-31	7.59%	CN¥600.00 Million ≈ $87.80 Million	CN¥7.90 Billion ≈ $1.16 Billion	-4.79pp
2017-12-31	12.38%	CN¥850.00 Million ≈ $124.38 Million	CN¥6.86 Billion ≈ $1.00 Billion	+11.39pp
2016-12-31	0.99%	CN¥65.00 Million ≈ $9.51 Million	CN¥6.53 Billion ≈ $956.15 Million	+0.62pp
2015-12-31	0.37%	CN¥20.00 Million ≈ $2.93 Million	CN¥5.39 Billion ≈ $788.27 Million	-4.18pp
2014-12-31	4.55%	CN¥210.00 Million ≈ $30.73 Million	CN¥4.62 Billion ≈ $675.47 Million	--

pp = percentage points

About Shenzhen Salubris Pharmaceuticals Co Ltd

SHE:002294 China Drug Manufacturers - Specialty & Generic

Market Cap

$5.14 Billion

CN¥35.12 Billion CNY

Market Cap Rank

#3422 Global

#431 in China

Share Price

CN¥31.50

Change (1 day)

+2.81%

52-Week Range

CN¥29.60 - CN¥68.30

All Time High

CN¥68.30